# OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol

> **NCT03881904** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 740 (estimated)

## Conditions studied

- Subfertility, Female

## Interventions

- **DRUG:** 0.075mg gestodene/0.03mg ethinylestradiol

## Key facts

- **NCT ID:** NCT03881904
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-01
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-07-01
- **Target enrollment:** 740 (ESTIMATED)
- **Last updated:** 2019-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03881904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03881904, "OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03881904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*